Global Peptide Therapeutics Market Growth (Status and Outlook) 2023-2029

Global Peptide Therapeutics Market Growth (Status and Outlook) 2023-2029

Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another.
LPI (LP Information)' newest research report, the “Peptide Therapeutics Industry Forecast” looks at past sales and reviews total world Peptide Therapeutics sales in 2022, providing a comprehensive analysis by region and market sector of projected Peptide Therapeutics sales for 2023 through 2029. With Peptide Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peptide Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Peptide Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Peptide Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Peptide Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peptide Therapeutics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peptide Therapeutics.
The global Peptide Therapeutics market size is projected to grow from US$ 33800 million in 2022 to US$ 63130 million in 2029; it is expected to grow at a CAGR of 9.3% from 2023 to 2029.
Global Peptide Therapeutics key players include Sanofi, Novo Nordisk, Takeda, Eli Lilly, Ipsen, etc. Global top five manufacturers hold a share about 65%.
North America is the largest market, with a share about 55%, followed by Europe and Asia-Pacific, both have a share about 40 percent.
In terms of product, Injection is the largest segment, with a share about 70%. And in terms of application, the largest application is Cancer, followed by Central Nervous System.
This report presents a comprehensive overview, market shares, and growth opportunities of Peptide Therapeutics market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Injection
Oral
Other
Segmentation by application
Cancer
Metabolic Disorders
Central Nervous System
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
AbbVie
Ipsen
Ferring
Merck
The Medicines
J & J

Please note: The report will take approximately 2 business days to prepare and deliver.